Bristol-Myers Squibb
Pharmaceutical & Health Products · Lobbying Client
C
Influence Score
56/100
Moderate Influence
$19.1M
Total Lobby Spend
6
Policy Issues
9
Lobbyists
1
Revolving Door
Bristol-Myers Squibb reported $19.1 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Commerce
National Science Foundation
Dept of Transportation
Dept of Defense
Dept of Health & Human Services
Federal Communications Commission
Dept of Justice
Dept of Labor
Federal Trade Commission
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Covington & Burling LLP | PHAHCRCPT | 1 | $791K |
| 2020 Apr-Jun | Cassidy & Associates LLP | HCRGOVMED | 4 | $1.0M |
| 2020 Jul-Sep | Brownstein Hyatt LLP | PHA | 2 | $957K |
| 2020 Oct-Dec | Squire Patton Boggs LLP | TAXPHAHCR+1 | 2 | $937K |
| 2021 Jan-Mar | Cassidy & Associates LLP | MEDTAXGOV+2 | 4 | $834K |
| 2021 Apr-Jun | K&L Gates LLP | CPTGOVPHA+1 | 2 | $1.1M |
| 2021 Jul-Sep | Cassidy & Associates LLP | CPTTAX | 2 | $634K |
| 2021 Oct-Dec | Squire Patton Boggs LLP | PHATAX | 4 | $930K |